HUT65846A - Method for preparation of o-glycosylated alpha-interferons and medicinal drugs containing it - Google Patents
Method for preparation of o-glycosylated alpha-interferons and medicinal drugs containing itInfo
- Publication number
- HUT65846A HUT65846A HU9300036A HU3693A HUT65846A HU T65846 A HUT65846 A HU T65846A HU 9300036 A HU9300036 A HU 9300036A HU 3693 A HU3693 A HU 3693A HU T65846 A HUT65846 A HU T65846A
- Authority
- HU
- Hungary
- Prior art keywords
- interferons
- preparation
- drugs containing
- medicinal drugs
- glycosylated
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/52—Cytokines; Lymphokines; Interferons
- C07K14/555—Interferons [IFN]
- C07K14/56—IFN-alpha
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Genetics & Genomics (AREA)
- General Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Molecular Biology (AREA)
- Medicinal Chemistry (AREA)
- Zoology (AREA)
- Biophysics (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Wood Science & Technology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biochemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Engineering & Computer Science (AREA)
- Biotechnology (AREA)
- Physics & Mathematics (AREA)
- Microbiology (AREA)
- Communicable Diseases (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Oncology (AREA)
- Plant Pathology (AREA)
- Gastroenterology & Hepatology (AREA)
- Virology (AREA)
- Toxicology (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
- Saccharide Compounds (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Polysaccharides And Polysaccharide Derivatives (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE19904021917 DE4021917A1 (de) | 1990-07-10 | 1990-07-10 | Glykosyliertes ifnalpha |
DE19904035877 DE4035877A1 (de) | 1990-11-12 | 1990-11-12 | O-glycosyliertes ifn-alfa2 |
Publications (2)
Publication Number | Publication Date |
---|---|
HU9300036D0 HU9300036D0 (en) | 1993-04-28 |
HUT65846A true HUT65846A (en) | 1994-07-28 |
Family
ID=25894855
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
HU9300036A HUT65846A (en) | 1990-07-10 | 1991-07-06 | Method for preparation of o-glycosylated alpha-interferons and medicinal drugs containing it |
Country Status (16)
Country | Link |
---|---|
EP (1) | EP0538300B1 (hu) |
JP (1) | JPH06502987A (hu) |
KR (1) | KR930701601A (hu) |
AT (1) | ATE104348T1 (hu) |
AU (1) | AU650893B2 (hu) |
CA (1) | CA2084514A1 (hu) |
CZ (1) | CZ386392A3 (hu) |
DE (1) | DE59101397D1 (hu) |
DK (1) | DK0538300T3 (hu) |
ES (1) | ES2063515T3 (hu) |
FI (1) | FI930058A0 (hu) |
HU (1) | HUT65846A (hu) |
NO (1) | NO930059L (hu) |
PL (1) | PL297610A1 (hu) |
SK (1) | SK386392A3 (hu) |
WO (1) | WO1992001055A1 (hu) |
Families Citing this family (37)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5541071A (en) * | 1992-02-07 | 1996-07-30 | New England Medical Center Hospitals, Inc. | Assay for identifying antagonists of gastrin and CCK-B receptors |
NZ245771A (en) * | 1992-02-07 | 1994-08-26 | New England Medical Center Inc | Mammalian gastrin/cholecystokinin b (cck-b) receptor and antagonists |
EP0626448A3 (de) * | 1993-05-26 | 1998-01-14 | BOEHRINGER INGELHEIM INTERNATIONAL GmbH | Verfahren zur Herstellung und Reinigung von alpha-Interferon |
AU713611B2 (en) * | 1994-10-28 | 1999-12-09 | Delft Diagnostic Laboratory B.V. | New polynucleic acid sequences for use in the detection and differentiation of prokaryotic organisms |
EP0920522B1 (en) * | 1996-08-14 | 2003-10-29 | THE GOVERNMENT OF THE UNITED STATES OF AMERICA, as represented by THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES | A vector for polynucleotide vaccines |
GB9904695D0 (en) * | 1999-03-01 | 1999-04-21 | Imp Cancer Res Tech | Peptide |
AU2001266557A1 (en) | 2000-04-12 | 2001-10-23 | Human Genome Sciences, Inc. | Albumin fusion proteins |
US7173003B2 (en) | 2001-10-10 | 2007-02-06 | Neose Technologies, Inc. | Granulocyte colony stimulating factor: remodeling and glycoconjugation of G-CSF |
EP2305311A3 (en) * | 2001-10-10 | 2011-07-20 | BioGeneriX AG | Glycoconjugation of peptides |
US7214660B2 (en) | 2001-10-10 | 2007-05-08 | Neose Technologies, Inc. | Erythropoietin: remodeling and glycoconjugation of erythropoietin |
EP2261250B1 (en) | 2001-12-21 | 2015-07-01 | Human Genome Sciences, Inc. | GCSF-Albumin fusion proteins |
KR20060003862A (ko) | 2003-03-14 | 2006-01-11 | 네오스 테크놀로지스, 인크. | 수용성분기폴리머 및 그 접합체 |
US8791070B2 (en) | 2003-04-09 | 2014-07-29 | Novo Nordisk A/S | Glycopegylated factor IX |
MXPA05010773A (es) | 2003-04-09 | 2005-12-12 | Neose Technologies Inc | Metodos de glicopegilacion y proteinas/peptidos producidos por los metodos. |
WO2005012484A2 (en) | 2003-07-25 | 2005-02-10 | Neose Technologies, Inc. | Antibody-toxin conjugates |
US8633157B2 (en) | 2003-11-24 | 2014-01-21 | Novo Nordisk A/S | Glycopegylated erythropoietin |
US20080305992A1 (en) | 2003-11-24 | 2008-12-11 | Neose Technologies, Inc. | Glycopegylated erythropoietin |
US20060040856A1 (en) | 2003-12-03 | 2006-02-23 | Neose Technologies, Inc. | Glycopegylated factor IX |
BRPI0506741A (pt) | 2004-01-08 | 2007-05-15 | Neose Technologies Inc | glicosilação de peptìdeos ligados a o |
US20080300173A1 (en) | 2004-07-13 | 2008-12-04 | Defrees Shawn | Branched Peg Remodeling and Glycosylation of Glucagon-Like Peptides-1 [Glp-1] |
US8268967B2 (en) | 2004-09-10 | 2012-09-18 | Novo Nordisk A/S | Glycopegylated interferon α |
JP5948627B2 (ja) | 2004-10-29 | 2016-07-20 | レイショファーム ゲーエムベーハー | 線維芽細胞成長因子(fgf)のリモデリングと糖質ペグ化 |
EP1858543B1 (en) | 2005-01-10 | 2013-11-27 | BioGeneriX AG | Glycopegylated granulocyte colony stimulating factor |
US20070154992A1 (en) | 2005-04-08 | 2007-07-05 | Neose Technologies, Inc. | Compositions and methods for the preparation of protease resistant human growth hormone glycosylation mutants |
JP5216580B2 (ja) | 2005-05-25 | 2013-06-19 | ノヴォ ノルディスク アー/エス | グリコペグ化第ix因子 |
US20070105755A1 (en) | 2005-10-26 | 2007-05-10 | Neose Technologies, Inc. | One pot desialylation and glycopegylation of therapeutic peptides |
US20090048440A1 (en) | 2005-11-03 | 2009-02-19 | Neose Technologies, Inc. | Nucleotide Sugar Purification Using Membranes |
AR078117A1 (es) | 2006-06-20 | 2011-10-19 | Protech Pharma S A | Una muteina recombinante del interferon alfa humano glicosilado, un gen que codifica para dicha muteina, un metodo de produccion de dicho gen, un metodo para obtener una celula eucariota productora de dicha muteina, un metodo para producir dicha muteina, un procedimiento para purificar dicha muteina |
CN101516388B (zh) | 2006-07-21 | 2012-10-31 | 诺和诺德公司 | 通过o-联糖基化序列的肽的糖基化 |
EP2054521A4 (en) | 2006-10-03 | 2012-12-19 | Novo Nordisk As | METHODS OF PURIFYING CONJUGATES OF POLYPEPTIDES |
RS52845B (en) | 2007-04-03 | 2013-12-31 | Biogenerix Ag | TREATMENT PROCEDURES USING GLYCOPEGILATED G-CSF |
US9493499B2 (en) | 2007-06-12 | 2016-11-15 | Novo Nordisk A/S | Process for the production of purified cytidinemonophosphate-sialic acid-polyalkylene oxide (CMP-SA-PEG) as modified nucleotide sugars via anion exchange chromatography |
US8207112B2 (en) | 2007-08-29 | 2012-06-26 | Biogenerix Ag | Liquid formulation of G-CSF conjugate |
EP2257311B1 (en) | 2008-02-27 | 2014-04-16 | Novo Nordisk A/S | Conjugated factor viii molecules |
WO2014102101A1 (en) | 2012-12-31 | 2014-07-03 | Boehringer Ingelheim International Gmbh | Novel intron sequences |
EP2938726B1 (en) | 2012-12-31 | 2017-09-27 | Boehringer Ingelheim International GmbH | Heterologous intron within a signal peptide |
RU2610173C1 (ru) * | 2016-03-30 | 2017-02-08 | Илья Александрович Марков | Рекомбинантная плазмида pFM-IFN-17, обеспечивающая экспрессию интерферона альфа-2b человека, рекомбинантная плазмида pFM-АР, обеспечивающая экспрессию фермента метионинаминопептидазы E. coli, биплазмидный штамм Escherichia coli FM-IFN-АР (pFM-IFN-17, pFM-АР) - продуцент (Met-) рекомбинантного интерферона альфа-2b человека |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
IN150740B (hu) * | 1978-11-24 | 1982-12-04 | Hoffmann La Roche | |
EP0085693A1 (en) * | 1981-08-14 | 1983-08-17 | A/S Alfred Benzon | Subjects relating to human inteferon-alpha subtype proteins and corresponding antibodies |
DE3306060A1 (de) * | 1983-02-22 | 1984-08-23 | Boehringer Ingelheim International GmbH, 6507 Ingelheim | Neue immunglobulin-produzierende hybridzellinien, deren verwendung und verfahren zu deren herstellung |
FR2560212B1 (fr) * | 1984-02-24 | 1989-12-29 | Unicet | Anticorps monoclonaux contre l'interferon a2 et hybridomes produisant de tels anticorps |
-
1991
- 1991-07-06 AU AU82082/91A patent/AU650893B2/en not_active Ceased
- 1991-07-06 SK SK3863-92A patent/SK386392A3/sk unknown
- 1991-07-06 PL PL29761091A patent/PL297610A1/xx unknown
- 1991-07-06 DK DK91912306.7T patent/DK0538300T3/da active
- 1991-07-06 JP JP3511638A patent/JPH06502987A/ja active Pending
- 1991-07-06 CA CA002084514A patent/CA2084514A1/en not_active Abandoned
- 1991-07-06 EP EP91912306A patent/EP0538300B1/de not_active Expired - Lifetime
- 1991-07-06 AT AT91912306T patent/ATE104348T1/de not_active IP Right Cessation
- 1991-07-06 ES ES91912306T patent/ES2063515T3/es not_active Expired - Lifetime
- 1991-07-06 DE DE59101397T patent/DE59101397D1/de not_active Expired - Fee Related
- 1991-07-06 WO PCT/EP1991/001266 patent/WO1992001055A1/de not_active Application Discontinuation
- 1991-07-06 KR KR1019930700049A patent/KR930701601A/ko not_active Application Discontinuation
- 1991-07-06 HU HU9300036A patent/HUT65846A/hu unknown
-
1992
- 1992-12-23 CZ CS923863A patent/CZ386392A3/cs unknown
-
1993
- 1993-01-08 FI FI930058A patent/FI930058A0/fi not_active Application Discontinuation
- 1993-01-08 NO NO93930059A patent/NO930059L/no unknown
Also Published As
Publication number | Publication date |
---|---|
DK0538300T3 (da) | 1994-10-10 |
NO930059D0 (no) | 1993-01-08 |
FI930058A (fi) | 1993-01-08 |
KR930701601A (ko) | 1993-06-12 |
AU650893B2 (en) | 1994-07-07 |
DE59101397D1 (de) | 1994-05-19 |
PL297610A1 (hu) | 1992-07-13 |
NO930059L (no) | 1993-01-08 |
WO1992001055A1 (de) | 1992-01-23 |
CA2084514A1 (en) | 1992-01-11 |
JPH06502987A (ja) | 1994-04-07 |
EP0538300A1 (de) | 1993-04-28 |
CZ386392A3 (en) | 1993-08-11 |
HU9300036D0 (en) | 1993-04-28 |
FI930058A0 (fi) | 1993-01-08 |
AU8208291A (en) | 1992-02-04 |
SK386392A3 (en) | 1994-08-10 |
ATE104348T1 (de) | 1994-04-15 |
EP0538300B1 (de) | 1994-04-13 |
ES2063515T3 (es) | 1995-01-01 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HUT65846A (en) | Method for preparation of o-glycosylated alpha-interferons and medicinal drugs containing it | |
HU9204034D0 (en) | Dialkoxi-pyridinyl-benzimidazole derivatives, method for producing them and their pharmaceutical application | |
EP0570916A3 (en) | Serum albumin, recombinant human, preparation process and pharmaceutical composition. | |
GR3007096T3 (hu) | ||
ID28003A (id) | Turunan-turunan adamantana | |
EP0534383A3 (en) | Process for preparing human coagulation factor viii protein complex | |
HU9301054D0 (en) | Method for producing cyclopeptides and pharmaceutical preparatives containing them | |
NO912825L (no) | Fremgangsmaate for fremstilling av kokonjugatvaksiner omfattende im munogent protein, hiv-beslektede peptider og anioniske grupper. | |
HU912013D0 (en) | Process for the production of benzopyrane derivatives and their heterocyclic analogues, antiyschemic medical preparations | |
HUT58764A (en) | Process for producing peptides, pharmaceutical compositions containing them and amino-acid intermediates | |
AU4987590A (en) | Process for the preparation of semi-aromatic polyamides | |
LTIP709A (en) | Sbstituted corticoid-17-alkylcarbonates, process for preparing thereof and pharmaceutical preparations | |
HU913450D0 (en) | Process for the production of cyclopeptides and medical preparations containing them | |
HU910929D0 (en) | Process for the production of 2,8-dioxa-bicyclo/3,2,1/octane derivatives and medical preparations containing them | |
HU913721D0 (en) | The use of xantine derivatives for the production of medical preparations preventing the immune system | |
AU2764888A (en) | Continuous process for the preparation of gelatin from powdered bone, and gelatin obtained | |
CS265391A3 (en) | Novel thienodiazepines, process for their preparation and pharmaceutical comprising them | |
EP0558961A3 (en) | Glycopeptide derivatives, process for their manufacture and pharmaceutical compositions comprising them | |
HU912517D0 (en) | New 1-diphenyl-methyl-piperazine derivatives, process for their production, and for the production of medical preparations containing thereof | |
PL292414A1 (en) | Method of obtaining complexes containing s-(+)-phenylalcanic and -hydroxyalcanic acids | |
GB9113096D0 (en) | Process for the separation of proteins,polypeptides or metals | |
DE68920445T2 (de) | Verfahren zur herstellung höchstreaktiver submikron amorpher titandiboridpulver und erzeugnisse daraus. | |
HU9203326D0 (en) | Method for producing 1,5-benzo-thiazepinone derivatives and pharmaceutical preparatives containing them | |
EP0325691A3 (en) | Process for the solubilization of insoluble protein | |
AU2715288A (en) | Human respiratory syncytialvirus vaccine derived from the 1a (9.5 kd) protein |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
DFD9 | Temporary protection cancelled due to non-payment of fee |